Sonova (OTCMKTS:SONVY) Hits New 12-Month High – Time to Buy?

by · The Markets Daily

Shares of Sonova Holding (OTCMKTS:SONVY – Get Free Report) reached a new 52-week high during trading on Monday. The stock traded as high as $69.01 and last traded at $69.01, with a volume of 4,451 shares. The stock had previously closed at $68.52.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the stock. The Goldman Sachs Group upgraded shares of Sonova from a “hold” rating to a “buy” rating in a report on Thursday, October 8th. Citigroup reiterated a “sell” rating on shares of Sonova in a research note on Friday, July 24th. Finally, UBS Group raised Sonova from a “hold” rating to a “buy” rating in a report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Sonova currently has a consensus rating of “Moderate Buy”.

Get Our Latest Research Report on SONVY

Sonova Price Performance

The stock’s fifty day simple moving average is $60.29 and its 200-day simple moving average is $53.70. The company has a quick ratio of 1.43, a current ratio of 1.75 and a debt-to-equity ratio of 0.51.

Sonova Company Profile

(Get Free Report)

Sonova Holding AG is a Switzerland-based hearing-care company that develops, manufactures and distributes solutions for people with hearing loss. Its portfolio includes hearing aids, cochlear implants, hearing implants, wireless communication products and related accessories and services.

The company markets products under several brands, including Phonak, Unitron and Advanced Bionics. Sonova also operates hearing-care businesses and retail networks that provide hearing assessments, device fitting, rehabilitation support and after-sales services.

Featured Articles